236 related articles for article (PubMed ID: 32326204)
1. Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity.
Llorach-Pares L; Rodriguez-Urgelles E; Nonell-Canals A; Alberch J; Avila C; Sanchez-Martinez M; Giralt A
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326204
[TBL] [Abstract][Full Text] [Related]
2. Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents.
Llorach-Pares L; Nonell-Canals A; Sanchez-Martinez M; Avila C
Mar Drugs; 2017 Nov; 15(12):. PubMed ID: 29186912
[TBL] [Abstract][Full Text] [Related]
3. Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer's Disease: A Computational Study.
Llorach-Pares L; Nonell-Canals A; Avila C; Sanchez-Martinez M
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30332805
[TBL] [Abstract][Full Text] [Related]
4. Meridianins: marine-derived potent kinase inhibitors.
Bharate SB; Yadav RR; Battula S; Vishwakarma RA
Mini Rev Med Chem; 2012 Jun; 12(7):618-31. PubMed ID: 22512550
[TBL] [Abstract][Full Text] [Related]
5. Epibrassinolide prevents tau hyperphosphorylation via GSK3β inhibition in vitro and improves Caenorhabditis elegans lifespan and motor deficits in combination with roscovitine.
Obakan Yerlikaya P; Arısan ED; Coker Gurkan A; Okumus OO; Yenigun T; Ozbey U; Kara M; Palavan Unsal N
Amino Acids; 2021 Sep; 53(9):1373-1389. PubMed ID: 34386848
[TBL] [Abstract][Full Text] [Related]
6. C-Glycosylflavones Alleviate Tau Phosphorylation and Amyloid Neurotoxicity through GSK3β Inhibition.
Liang Z; Zhang B; Su WW; Williams PG; Li QX
ACS Chem Neurosci; 2016 Jul; 7(7):912-23. PubMed ID: 27213824
[TBL] [Abstract][Full Text] [Related]
7. Theoretical Studies on the Selectivity Mechanisms of Glycogen Synthase Kinase 3β (GSK3β) with Pyrazine ATP-competitive Inhibitors by 3DQSAR, Molecular Docking, Molecular Dynamics Simulation and Free Energy Calculations.
Zhu J; Wu Y; Xu L; Jin J
Curr Comput Aided Drug Des; 2020; 16(1):17-30. PubMed ID: 31284868
[TBL] [Abstract][Full Text] [Related]
8. Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum.
Gompel M; Leost M; De Kier Joffe EB; Puricelli L; Franco LH; Palermo J; Meijer L
Bioorg Med Chem Lett; 2004 Apr; 14(7):1703-7. PubMed ID: 15026054
[TBL] [Abstract][Full Text] [Related]
9. Meridianins Inhibit GSK3β In Vivo and Improve Behavioral Alterations Induced by Chronic Stress.
Sancho-Balsells A; García-García E; Flotta F; Chen W; Alberch J; Rodríguez MJ; Avila C; Giralt A
Mar Drugs; 2022 Oct; 20(10):. PubMed ID: 36286471
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones.
Liang Z; Li QX
ACS Chem Neurosci; 2018 May; 9(5):1166-1183. PubMed ID: 29381861
[TBL] [Abstract][Full Text] [Related]
11. Structural modeling of GSK3β implicates the inactive (DFG-out) conformation as the target bound by TDZD analogs.
Balasubramaniam M; Mainali N; Bowroju SK; Atluri P; Penthala NR; Ayyadevera S; Crooks PA; Shmookler Reis RJ
Sci Rep; 2020 Oct; 10(1):18326. PubMed ID: 33110096
[TBL] [Abstract][Full Text] [Related]
12. Meridianins Rescue Cognitive Deficits, Spine Density and Neuroinflammation in the 5xFAD Model of Alzheimer's Disease.
Rodríguez-Urgellés E; Sancho-Balsells A; Chen W; López-Molina L; Ballasch I; Del Castillo I; Avila C; Alberch J; Giralt A
Front Pharmacol; 2022; 13():791666. PubMed ID: 35281935
[TBL] [Abstract][Full Text] [Related]
13. Identification of two potential glycogen synthase kinase 3β inhibitors for the treatment of osteosarcoma.
Lu K; Wang X; Chen Y; Liang D; Luo H; Long L; Hu Z; Bao J
Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):456-464. PubMed ID: 29546355
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine.
Jiang X; Liu C; Zou M; Xie H; Lin T; Lyu W; Xu J; Li Y; Feng F; Sun H; Liu W
Eur J Med Chem; 2021 Nov; 223():113663. PubMed ID: 34198150
[TBL] [Abstract][Full Text] [Related]
15. Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.
Zhang N; Zhong R; Yan H; Jiang Y
Chem Biol Drug Des; 2011 Mar; 77(3):199-205. PubMed ID: 21244636
[TBL] [Abstract][Full Text] [Related]
16. Targeting Tau Hyperphosphorylation
Turab Naqvi AA; Hasan GM; Hassan MI
Curr Top Med Chem; 2020; 20(12):1059-1073. PubMed ID: 31903881
[TBL] [Abstract][Full Text] [Related]
17. Application of Fragment-Based de Novo Design to the Discovery of Selective Picomolar Inhibitors of Glycogen Synthase Kinase-3 Beta.
Park H; Shin Y; Kim J; Hong S
J Med Chem; 2016 Oct; 59(19):9018-9034. PubMed ID: 27676184
[TBL] [Abstract][Full Text] [Related]
18. Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.
Nikolaou PE; Boengler K; Efentakis P; Vouvogiannopoulou K; Zoga A; Gaboriaud-Kolar N; Myrianthopoulos V; Alexakos P; Kostomitsopoulos N; Rerras I; Tsantili-Kakoulidou A; Skaltsounis AL; Papapetropoulos A; Iliodromitis EK; Schulz R; Andreadou I
Cardiovasc Res; 2019 Jun; 115(7):1228-1243. PubMed ID: 30843027
[TBL] [Abstract][Full Text] [Related]
19. In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains.
Krishnankutty A; Kimura T; Saito T; Aoyagi K; Asada A; Takahashi SI; Ando K; Ohara-Imaizumi M; Ishiguro K; Hisanaga SI
Sci Rep; 2017 Aug; 7(1):8602. PubMed ID: 28819213
[TBL] [Abstract][Full Text] [Related]
20. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
